Daan Gene Co., Ltd. (SHE:002030)
6.32
+0.01 (0.16%)
Jan 23, 2026, 10:10 AM CST
Daan Gene Revenue
Daan Gene had revenue of 164.93M CNY in the quarter ending September 30, 2025, a decrease of -13.50%. This brings the company's revenue in the last twelve months to 765.48M, down -17.66% year-over-year. In the year 2024, Daan Gene had annual revenue of 853.02M, down -27.76%.
Revenue (ttm)
765.48M
Revenue Growth
-17.66%
P/S Ratio
11.57
Revenue / Employee
442.47K
Employees
1,730
Market Cap
8.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 853.02M | -327.87M | -27.76% |
| Jan 1, 2024 | 1.18B | -10.87B | -90.20% |
| Jan 1, 2023 | 12.05B | 4.38B | 57.17% |
| Jan 1, 2022 | 7.66B | 2.32B | 43.49% |
| Dec 31, 2020 | 5.34B | 4.24B | 386.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chengzhi | 11.53B |
| Anhui Huaheng Biotechnology | 2.83B |
| Nanjing Vazyme Biotech | 1.34B |
| Chengdu Kanghua Biological Products | 1.21B |
| Shanghai Medicilon | 1.08B |
| Wuhan Keqian Biology Co.,Ltd | 1.01B |
| Jiangxi Fushine Pharmaceutical | 970.32M |
| Acrobiosystems | 794.52M |